5:08 PM ET
8-K
M&A Deal
Adial Pharmaceuticals M&A Deal with Azora Therapeutics, Inc.
Adial Pharmaceuticals provided a status update on its previously announced acquisition of Azora Therapeutics, including the entry into amendments to the Securities Purchase Agreement and Note Exchange Agreements. The amendments remove a 'Penalty Provision' related to Milestone Warrants and add lock-up restrictions, resulting in a reclassification of certain warrant rights from liability to equity on the company's balance sheet.
- Counterparty
- Azora Therapeutics, Inc.